GlassScriptPhysician profile
Ilitch Diaz Gutierrez
NPI 1629209366
$727.88
in general payments reported to CMS, 2019-2025
12 companies · $75.06 in 2025
The $75.06 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $293 · 2020: $13.83 · 2021: $212 · 2022: $72.96 · 2023: $43.25 · 2024: $17.57 · 2025: $75.06.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $136.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $135.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $199.98 | 2021-2024 | |
| Medical Device Business Services, INC. | $120.94 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $97.41 | 2022-2025 | Opdivo |
| Zimmer Biomet Holdings, INC. | $80.24 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $38.64 | 2019-2022 | |
| G1 Therapeutics, INC. | $37.31 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $37.30 | 2019 | |
| Kls-Martin L.P. | $29.99 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $29.25 | 2019-2023 | Gilotrif |
| Ethicon US, LLC | $27.38 | 2019 | |
| Mirati Therapeutics, INC. | $15.68 | 2023 | Krazati |
| Lilly USA, LLC | $13.76 | 2023 | Verzenio, Retevmo, Jaypirca |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ilitch Diaz Gutierrez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.